Meta-Analysis Results on Pharmacist Impact on Vancomycin Monitoring

A systematic review and meta-analysis of 63 clinical studies evaluates pharmacist interventions on vancomycin therapeutic drug monitoring. The dataset likely contains aggregated statistical results comparing outcomes like acute kidney injury incidence and mortality rates between intervention and control groups. The analysis was conducted using Stata 18.0 and is published under a CC-BY-4.0 license.

Use Cases

• Evaluate the effect of pharmacist interventions on acute kidney injury incidence based on the reported risk ratios
• Analyze improvements in target blood concentration attainment rates under pharmacist guidance
• Compare clinical effective rates and mortality outcomes between intervention and non-intervention groups
• Investigate subgroup analysis results for different vancomycin target ranges and kidney injury definitions

Strengths

• Includes results from 63 clinical studies, providing a substantial evidence base
• Reports specific statistical outcomes for multiple key clinical metrics, such as risk ratios and confidence intervals
• Conducted using Cochrane systematic review methodology, suggesting a rigorous approach

Limitations

• The dataset is a 43.3 KB DOCX file, likely containing summary tables or text, not raw study data
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment for certain analyses

Provenance

Source

figshare

Collection Method

Meta-analysis performed using Stata 18.0 after systematic review of databases including PubMed, Medline, Embase, Cochrane Library, CNKI, and Sinomed.

Freshness

Last updated 2026-04-29 05:57:30; freshness should be verified